Treatment for delaying conversion of the first demyelinating event to multiple sclerosis: a Cochrane review on use of recombinant interferon beta or glatiramer acetate

Liknande verk

• Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.
  av: Clerico, M, et al.
  Publicerad: (2008)
• Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.
  av: Clerico, M, et al.
  Publicerad: (2008)
• Recombinant interferon-beta efficacy in preventing conversion of clinically isolated syndromes to clinically defined multiple sclerosis: a Cochrane meta-analysis
  av: Clerico, M, et al.
  Publicerad: (2006)
• Early treatment to prevent conversion of clinically isolated syndrome to clinically defined multiple sclerosis: a Cochrane metanalysis
  av: Clerico, M, et al.
  Publicerad: (2008)
• Conversion from clinically isolated syndromes to multiple sclerosis: how could we prevent it? A Cochrane review of published trials
  av: Clerico, M, et al.
  Publicerad: (2007)